Skip to main content
TipRanks
Go Ultimate75% OFF

AN2 Therapeutics, Inc. (ANTX) Hedge Fund Trading Activity

108 Followers
Trend: ▲ Hedge Funds Increased Holdings by 812.9K Shares Last Quarter

Hedge Fund Holdings in ANTX

0.00$0.981.50M$2.363.00M$3.744.50M$5.126.00M$6.50Jul '24Jan '25Jul '25Jan '26Jul '26$4.55Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
BlackRock, Inc. hedge funds manager,  ,Rank 332BlackRock, Inc. Added422.48%$8,060,991<0.01%
Michael Rockefeller hedge funds manager, Woodline Partners LP,Rank 458Michael RockefellerWoodline Partners LPReduced-53.73%$2,225,456<0.01%

FAQ

Which hedge funds hold AN2 Therapeutics, Inc.?
Currently, no data Available
Are hedge funds buying or selling ANTX?
In the last quarter hedge funds have Increased their holdings in AN2 Therapeutics, Inc. by 812.9K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in AN2 Therapeutics, Inc. stock?
Warren Buffet currently does not own shares in AN2 Therapeutics, Inc..
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here